Cargando…
The breadth of maternal HIV-1 specific neutralizing antibodies is not associated with a lower risk of mother-to-infant transmission
Autores principales: | Chaillon, A, Wack, T, Braibant, M, Mandelbrot, L, Blanche, S, Warszawski, J, Barin, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442030/ http://dx.doi.org/10.1186/1742-4690-9-S2-P44 |
Ejemplares similares
-
P04-17. The N-glycosylation sites N295, N332 and N392 of gp120 are necessary but not sufficient for HIV-1 to be neutralized by 2G12
por: Chaillon, A, et al.
Publicado: (2009) -
Continuous evolution of HIV-1 more than ten years after infection in an elite neutralizer
por: Chaillon, A, et al.
Publicado: (2012) -
P04-53 LB. Potent and broad HIV-specific neutralizing antibodies in infants are not associated with prevention of mother to infant HIV transmission
por: Lynch, J, et al.
Publicado: (2009) -
The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context?
por: Braibant, Martine, et al.
Publicado: (2013) -
Native envelope-based immunogens derived from critical timepoints in the development of breadth elicit rapid neutralizing antibodies in rabbits
por: Malherbe, DC, et al.
Publicado: (2012)